Volume 8 Issue 2, Feb 2023

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 8 Issue 2, Feb 2023:
Letter
Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1′-CN-4-aza-7,9-dideazaadenosine C-nucleoside
Qifan Zhou,Sidi Yang,Liu Cao,Yang Yang,Tiefeng Xu,Qishu Chen,Hongzhou Lu,Yingjun Li,Deyin Guo  ORCID: orcid.org/0000-0002-8297-0814 &…Xumu Zhang